Posted by Michael Wonder on 31 Jul 2018
New epilepsy medicine to provide much needed support to thousands of Australians
28 July 2018 - Almost 6,500 patients who suffer from particularly severe epilepsy will receive much-needed support with the Australian Government subsidising a life-changing medicine, saving families thousands of dollars each year.
From August 1, Perampanel will be listed on the Pharmaceutical Benefits Scheme for children older than 12 and adults with severe epilepsy.
This will save each patient and their family just under $5,000 each year and will now mean patients pay a maximum of $39.50 per script or just $6.40 per script for concessional patients.
